The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector. It will invest in securities of issuers among a number of different countries throughout the world, one of which may be the United States. The portfolio managers use fundamental and quantitative analyses to select individual securities, and they may invest more than 5% of the fund's assets in any one issuer. The fund participates in the initial public offering (IPO) market. It is non-diversified.
Fund filings (PDF) »
David Chan (Started: Jun 30, 1999)
Michael Del Balso (Started: Oct 25, 2000)
# Contact ?>
JennisonDryden, One Seaport Plaza, New York, NY 10292, United States